$VPHM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VIROPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VIROPHARMA INC. Get notifications about new insider transactions in VIROPHARMA INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2010 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | P | 12.52 | 10,000 | 125,203 | 83,638 | 73.6 K to 83.6 K (+13.58 %) |
May 10 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Sell | S | 12.70 | 52,508 | 666,930 | 248,829 | 301.3 K to 248.8 K (-17.43 %) |
May 10 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Sell | S | 12.46 | 11,104 | 138,338 | 301,337 | 312.4 K to 301.3 K (-3.55 %) |
May 10 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Sell | S | 12.62 | 7,103 | 89,672 | 312,441 | 319.5 K to 312.4 K (-2.22 %) |
May 10 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Sell | S | 12.65 | 25,405 | 321,310 | 319,544 | 344.9 K to 319.5 K (-7.36 %) |
May 04 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.78 | 134,727 | 1,721,286 | 3,135,799 | 3 M to 3.1 M (+4.49 %) |
May 04 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.76 | 263,216 | 3,358,557 | 3,001,072 | 2.7 M to 3 M (+9.61 %) |
May 04 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.98 | 225,068 | 2,921,518 | 2,737,856 | 2.5 M to 2.7 M (+8.96 %) |
May 04 2010 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 13.03 | 618,993 | 8,066,036 | 2,512,788 | 1.9 M to 2.5 M (+32.69 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.78 | 145,971 | 1,864,940 | 9,080,664 | 8.9 M to 9.1 M (+1.63 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.76 | 285,183 | 3,638,850 | 8,934,693 | 8.6 M to 8.9 M (+3.30 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.98 | 243,852 | 3,165,345 | 8,649,510 | 8.4 M to 8.6 M (+2.90 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 13.03 | 670,652 | 8,739,199 | 8,405,658 | 7.7 M to 8.4 M (+8.67 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.73 | 232,656 | 2,962,316 | 7,735,006 | 7.5 M to 7.7 M (+3.10 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.70 | 348,500 | 4,426,821 | 7,502,350 | 7.2 M to 7.5 M (+4.87 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.79 | 19,463 | 249,014 | 7,153,850 | 7.1 M to 7.2 M (+0.27 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.78 | 4,029 | 51,475 | 241,295 | 237.3 K to 241.3 K (+1.70 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.76 | 7,872 | 100,444 | 237,266 | 229.4 K to 237.3 K (+3.43 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.98 | 6,731 | 87,372 | 229,394 | 222.7 K to 229.4 K (+3.02 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 13.03 | 18,512 | 241,228 | 222,663 | 204.2 K to 222.7 K (+9.07 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.73 | 6,422 | 81,769 | 204,151 | 197.7 K to 204.2 K (+3.25 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.70 | 9,620 | 122,198 | 197,729 | 188.1 K to 197.7 K (+5.11 %) |
Apr 30 2010 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.79 | 537 | 6,870 | 188,109 | 187.6 K to 188.1 K (+0.29 %) |
Feb 23 2010 | VPHM | VIROPHARMA INC | BALDINO FRANK JR | Director | Option Exercise | A | 10.76 | 15,000 | 161,400 | 15,000 | |
Feb 23 2010 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | A | 10.76 | 15,000 | 161,400 | 15,000 | |
Feb 23 2010 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | A | 10.76 | 15,000 | 161,400 | 15,000 | |
Feb 23 2010 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 10.76 | 15,000 | 161,400 | 15,000 | |
Feb 23 2010 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | A | 10.76 | 15,000 | 161,400 | 15,000 | |
Feb 23 2010 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | A | 10.76 | 15,000 | 161,400 | 15,000 | |
Feb 23 2010 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | A | 10.76 | 15,000 | 161,400 | 15,000 | |
Jan 08 2010 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | A | 8.86 | 12,500 | 110,750 | 12,500 | |
Jan 08 2010 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Option Exercise | A | 8.86 | 5,000 | 44,300 | 5,000 | |
Jan 08 2010 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | A | 8.86 | 125,000 | 1,107,500 | 125,000 | |
Jan 08 2010 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | A | 8.86 | 100,000 | 886,000 | 100,000 | |
Jan 08 2010 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | A | 8.86 | 100,000 | 886,000 | 100,000 | |
Jan 08 2010 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | A | 8.86 | 180,000 | 1,594,800 | 180,000 | |
Jan 08 2010 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 8.86 | 100,000 | 886,000 | 100,000 | |
Jan 08 2010 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | A | 8.86 | 125,000 | 1,107,500 | 125,000 | |
Jun 15 2009 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 5.91 | 40,000 | 236,400 | 40,000 | |
Jun 15 2009 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | A | 5.91 | 40,000 | 236,400 | 40,000 | |
Jun 15 2009 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | A | 5.91 | 40,000 | 236,400 | 40,000 | |
Jun 15 2009 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | A | 5.91 | 40,000 | 236,400 | 40,000 | |
Jun 15 2009 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | A | 5.91 | 56,000 | 330,960 | 56,000 | |
Jun 15 2009 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | A | 5.91 | 50,000 | 295,500 | 50,000 | |
Jun 15 2009 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Option Exercise | A | 5.91 | 4,000 | 23,640 | 4,000 | |
Jun 15 2009 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | A | 5.91 | 8,000 | 47,280 | 8,000 | |
Jun 08 2009 | VPHM | VIROPHARMA INC | BALDINO FRANK JR | Director | Option Exercise | A | 6.10 | 7,500 | 45,750 | 7,500 | |
Jun 08 2009 | VPHM | VIROPHARMA INC | BALDINO FRANK JR | Director | Option Exercise | A | 6.10 | 25,000 | 152,500 | 25,000 | |
May 26 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.10 | 81 | 494 | 187,572 | 187.5 K to 187.6 K (+0.04 %) |
May 26 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.08 | 487 | 2,963 | 187,491 | 187 K to 187.5 K (+0.26 %) |
May 26 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.08 | 495 | 3,010 | 187,004 | 186.5 K to 187 K (+0.27 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 6.10 | 2,910 | 17,744 | 7,134,387 | 7.1 M to 7.1 M (+0.04 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 6.08 | 17,459 | 106,228 | 7,131,477 | 7.1 M to 7.1 M (+0.25 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 6.08 | 17,751 | 107,940 | 7,114,018 | 7.1 M to 7.1 M (+0.25 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.10 | 7 | 43 | 84,425 | 84.4 K to 84.4 K (+0.01 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.08 | 39 | 237 | 84,418 | 84.4 K to 84.4 K (+0.05 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.08 | 40 | 243 | 84,379 | 84.3 K to 84.4 K (+0.05 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.10 | 2 | 12 | 105,798 | 105.8 K to 105.8 K (0.00 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.08 | 11 | 67 | 105,796 | 105.8 K to 105.8 K (+0.01 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.08 | 11 | 67 | 105,785 | 105.8 K to 105.8 K (+0.01 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 110 | 660 | 84,339 | 84.2 K to 84.3 K (+0.13 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.98 | 73 | 437 | 84,229 | 84.2 K to 84.2 K (+0.09 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.99 | 52 | 312 | 84,156 | 84.1 K to 84.2 K (+0.06 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.84 | 12 | 70 | 84,104 | 84.1 K to 84.1 K (+0.01 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.87 | 37 | 217 | 84,092 | 84.1 K to 84.1 K (+0.04 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 98 | 588 | 84,055 | 84 K to 84.1 K (+0.12 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 31 | 186 | 105,774 | 105.7 K to 105.8 K (+0.03 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.98 | 21 | 126 | 105,743 | 105.7 K to 105.7 K (+0.02 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.99 | 15 | 90 | 105,722 | 105.7 K to 105.7 K (+0.01 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.84 | 3 | 18 | 105,707 | 105.7 K to 105.7 K (0.00 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.87 | 10 | 59 | 105,704 | 105.7 K to 105.7 K (+0.01 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 28 | 168 | 105,694 | 105.7 K to 105.7 K (+0.03 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 6.00 | 48,508 | 291,048 | 7,096,267 | 7 M to 7.1 M (+0.69 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.98 | 32,483 | 194,310 | 7,047,759 | 7 M to 7 M (+0.46 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.99 | 23,181 | 138,880 | 7,015,276 | 7 M to 7 M (+0.33 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.84 | 5,239 | 30,608 | 6,992,095 | 7 M to 7 M (+0.07 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.87 | 16,299 | 95,634 | 6,986,856 | 7 M to 7 M (+0.23 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 6.00 | 43,402 | 260,555 | 6,970,557 | 6.9 M to 7 M (+0.63 %) |
May 20 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 1,351 | 8,106 | 186,509 | 185.2 K to 186.5 K (+0.73 %) |
May 20 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.98 | 905 | 5,414 | 185,158 | 184.3 K to 185.2 K (+0.49 %) |
May 20 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.99 | 646 | 3,870 | 184,253 | 183.6 K to 184.3 K (+0.35 %) |
May 20 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.84 | 146 | 853 | 183,607 | 183.5 K to 183.6 K (+0.08 %) |
May 20 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.87 | 454 | 2,664 | 183,461 | 183 K to 183.5 K (+0.25 %) |
May 20 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 1,209 | 7,258 | 183,007 | 181.8 K to 183 K (+0.67 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.46 | 679 | 3,706 | 83,957 | 83.3 K to 84 K (+0.82 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.46 | 157 | 858 | 83,278 | 83.1 K to 83.3 K (+0.19 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.45 | 160 | 872 | 83,121 | 83 K to 83.1 K (+0.19 %) |
May 15 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.46 | 8,368 | 45,671 | 181,798 | 173.4 K to 181.8 K (+4.83 %) |
May 15 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.46 | 1,939 | 10,591 | 173,430 | 171.5 K to 173.4 K (+1.13 %) |
May 15 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.45 | 1,972 | 10,754 | 171,491 | 169.5 K to 171.5 K (+1.16 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.46 | 300,268 | 1,638,803 | 6,927,155 | 6.6 M to 6.9 M (+4.53 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.46 | 69,581 | 380,051 | 6,626,887 | 6.6 M to 6.6 M (+1.06 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.45 | 70,774 | 385,938 | 6,557,306 | 6.5 M to 6.6 M (+1.09 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.46 | 190 | 1,037 | 105,666 | 105.5 K to 105.7 K (+0.18 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.46 | 44 | 240 | 105,476 | 105.4 K to 105.5 K (+0.04 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.45 | 45 | 245 | 105,432 | 105.4 K to 105.4 K (+0.04 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.86 | 61 | 357 | 105,387 | 105.3 K to 105.4 K (+0.06 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.92 | 83 | 492 | 105,326 | 105.2 K to 105.3 K (+0.08 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.73 | 48 | 275 | 105,243 | 105.2 K to 105.2 K (+0.05 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.72 | 90 | 515 | 105,195 | 105.1 K to 105.2 K (+0.09 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.86 | 219 | 1,283 | 82,961 | 82.7 K to 83 K (+0.26 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.92 | 298 | 1,765 | 82,742 | 82.4 K to 82.7 K (+0.36 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.73 | 173 | 991 | 82,444 | 82.3 K to 82.4 K (+0.21 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.72 | 321 | 1,836 | 82,271 | 82 K to 82.3 K (+0.39 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.86 | 96,725 | 566,654 | 6,486,532 | 6.4 M to 6.5 M (+1.51 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.92 | 131,661 | 779,933 | 6,389,807 | 6.3 M to 6.4 M (+2.10 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.73 | 76,403 | 437,613 | 6,258,146 | 6.2 M to 6.3 M (+1.24 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.72 | 142,068 | 812,530 | 6,181,743 | 6 M to 6.2 M (+2.35 %) |
May 11 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.86 | 2,695 | 15,788 | 169,519 | 166.8 K to 169.5 K (+1.62 %) |
May 11 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.92 | 3,669 | 21,734 | 166,824 | 163.2 K to 166.8 K (+2.25 %) |
May 11 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.73 | 2,129 | 12,194 | 163,155 | 161 K to 163.2 K (+1.32 %) |
May 11 2009 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.72 | 3,959 | 22,643 | 161,026 | 157.1 K to 161 K (+2.52 %) |
Mar 13 2009 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Buy | P | 4.05 | 30,000 | 121,500 | 70,000 | 40 K to 70 K (+75.00 %) |
Mar 03 2009 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Grant | A | 4.06 | 3,000 | 12,180 | 41,860 | 44.9 K to 41.9 K (-6.69 %) |
Feb 27 2009 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Buy | P | 3.97 | 20,000 | 79,320 | 60,000 | 40 K to 60 K (+50.00 %) |
Feb 27 2009 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | P | 3.94 | 5,000 | 19,700 | 50,807 | 45.8 K to 50.8 K (+10.92 %) |
Feb 27 2009 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | P | 4.79 | 4,183 | 20,037 | 24,000 | 19.8 K to 24 K (+21.11 %) |
Feb 27 2009 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | P | 4.78 | 11,817 | 56,485 | 19,817 | 8 K to 19.8 K (+147.71 %) |
Feb 27 2009 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | P | 4.01 | 300 | 1,203 | 66,367 | 66.7 K to 66.4 K (-0.45 %) |
Feb 27 2009 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | P | 4.18 | 1,805 | 7,545 | 66,067 | 67.9 K to 66.1 K (-2.66 %) |
Feb 27 2009 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Sell | P | 4.21 | 195 | 821 | 64,262 | 64.5 K to 64.3 K (-0.30 %) |
Feb 25 2009 | VPHM | VIROPHARMA INC | PIEN HOWARD H | Director | Option Exercise | A | 5.68 | 15,000 | 85,200 | 15,000 | |
Feb 25 2009 | VPHM | VIROPHARMA INC | Leone John R | Director | Option Exercise | A | 5.68 | 15,000 | 85,200 | 15,000 | |
Feb 25 2009 | VPHM | VIROPHARMA INC | GLASER ROBERT | Director | Option Exercise | A | 5.68 | 15,000 | 85,200 | 15,000 | |
Feb 25 2009 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 5.68 | 15,000 | 85,200 | 15,000 | |
Feb 25 2009 | VPHM | VIROPHARMA INC | CLAYPOOL WILLIAM D MD | Director | Option Exercise | A | 5.68 | 15,000 | 85,200 | 15,000 | |
Feb 25 2009 | VPHM | VIROPHARMA INC | BROOKE PAUL A | Director | Option Exercise | A | 5.68 | 15,000 | 85,200 | 15,000 | |
Jan 13 2009 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | M | 11.63 | 22,500 | 261,563 | 0 | |
Jan 13 2009 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Payment of Exercise | F | 13.50 | 19,375 | 261,563 | 64,067 | 83.4 K to 64.1 K (-23.22 %) |
Jan 13 2009 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Buy | M | 11.63 | 22,500 | 261,563 | 83,442 | 60.9 K to 83.4 K (+36.92 %) |
Jan 13 2009 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | M | 11.63 | 22,500 | 261,563 | 0 | |
Jan 13 2009 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Payment of Exercise | F | 13.50 | 19,375 | 261,563 | 45,807 | 65.2 K to 45.8 K (-29.72 %) |
Jan 13 2009 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Buy | M | 11.63 | 22,500 | 261,563 | 65,182 | 42.7 K to 65.2 K (+52.72 %) |
Jan 12 2009 | VPHM | VIROPHARMA INC | Morris Richard Steven | Chief Accounting Of ... | Option Exercise | A | 13.50 | 6,500 | 87,750 | 6,500 | |
Jan 12 2009 | VPHM | VIROPHARMA INC | DOYLE THOMAS F | VP Strategic Initia ... | Option Exercise | A | 13.50 | 60,000 | 810,000 | 60,000 | |
Jan 12 2009 | VPHM | VIROPHARMA INC | Broom Colin MD | VP & Chief Scientif ... | Option Exercise | A | 13.50 | 60,000 | 810,000 | 60,000 | |
Jan 12 2009 | VPHM | VIROPHARMA INC | MILANO VINCENT | President and CEO | Option Exercise | A | 13.50 | 84,000 | 1,134,000 | 84,000 | |
Jan 12 2009 | VPHM | VIROPHARMA INC | Pietrusko Robert | VP, Regulatory & Qu ... | Option Exercise | A | 13.50 | 60,000 | 810,000 | 60,000 | |
Jan 12 2009 | VPHM | VIROPHARMA INC | SOLAND DANIEL B | VP, Chief Operating ... | Option Exercise | A | 13.50 | 75,000 | 1,012,500 | 75,000 | |
Jan 12 2009 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Option Exercise | A | 13.50 | 60,000 | 810,000 | 60,000 | |
Jan 12 2009 | VPHM | VIROPHARMA INC | Wolf John Peter III | VP, General Counsel | Option Exercise | A | 13.50 | 12,000 | 162,000 | 12,000 | |
Nov 12 2008 | VPHM | VIROPHARMA INC | DE ROSEN MICHEL | Director | Sell | S | 12.30 | 7,747 | 95,288 | 137,100 | 144.8 K to 137.1 K (-5.35 %) |
Nov 12 2008 | VPHM | VIROPHARMA INC | DE ROSEN MICHEL | Director | Sell | S | 12.15 | 292,930 | 3,558,133 | 144,847 | 437.8 K to 144.8 K (-66.91 %) |
Nov 05 2008 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | VP, Chief Financial ... | Buy | P | 12.77 | 8,000 | 102,160 | 8,000 | 0 to 8 K |
Nov 05 2008 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | M | 3.00 | 25,000 | 75,000 | 25,000 | |
Nov 05 2008 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Option Exercise | M | 3.42 | 20,000 | 68,400 | 20,000 | |
Nov 05 2008 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Sell | S | 12.76 | 45,000 | 574,263 | 0 | 45 K to 0 (-100.00 %) |
Nov 05 2008 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Buy | M | 3.00 | 25,000 | 75,000 | 45,000 | 20 K to 45 K (+125.00 %) |
Nov 05 2008 | VPHM | VIROPHARMA INC | DOUGHERTY MICHAEL R | Director | Buy | M | 3.42 | 20,000 | 68,400 | 20,000 | 0 to 20 K |
Oct 21 2008 | VPHM | VIROPHARMA INC | Rowland Charles A Jr | Chief Financial Off ... | Option Exercise | A | 11.96 | 100,000 | 1,196,000 | 100,000 |